Bernstein downgrades BellRing Brands stock rating on pricing pressure By Investing.com

Bernstein SocGen Group downgraded BellRing Brands to Market Perform from Outperform and cut its price target to $11 from $35, citing worsening promotional pressure, weaker base volumes for Premier Protein, and rising input and freight costs. The firm said its prior bullish thesis is broken, and the stock also recently reported fiscal Q2 2026 EPS of $0.14 versus $0.32 expected and revenue of $598.7 million versus $608.82 million expected. The downgrade and earnings miss point to margin headwinds into late fiscal 2026 and fiscal 2027.

Analysis

This is less about one bad quarter and more about a category-level reset in protein drinks. The key second-order effect is that branded mix is becoming less defensible just as input-cost inflation is re-accelerating, which compresses the “volume growth at scale” narrative that supported the stock’s premium multiple. If smaller competitors are willing to keep leaning on promotions, BellRing is forced into a prisoner’s-dilemma outcome: defend share and sacrifice margin, or protect margin and lose shelf velocity.

The cost setup matters because the margin hit is likely delayed, not immediate, which can keep consensus too optimistic for another one or two quarters. That creates a classic earnings-estimate trap: reported margins may look manageable until the input lag catches up in late FY26, then negative revisions can cascade into FY27. Freight is the quieter problem here — it is regressive against smaller manufacturers, so BellRing’s scale advantage narrows exactly when it needs it most.

COST and KO are mild relative winners in the sense that their supply-chain leverage and pricing architecture make them better able to absorb or pass through inflation. But the bigger beneficiary may be private-label or smaller “deal” brands that can win share in a price-sensitive environment; the category may grow, but the economics shift away from the premium incumbent. The stock’s collapse has already de-rated a lot of the bad news, so the tactical question is not valuation, but whether earnings revisions still have further to go from here.

Key Decisions for Investors

• Maintain/establish a short BRBR position on any post-downgrade bounce; best risk/reward is over the next 1-3 months into the next guidance cycle, with upside capped by already-stressed valuation but downside still open if revenue/margin revisions continue.
• Use a put spread in BRBR (e.g., 1-2 quarters out) to express downside while limiting premium burn; structure for a move to new cycle lows if promotional intensity and input costs remain sticky into FY26.
• Pair trade: short BRBR / long COST as a relative-quality trade over 3-6 months; COST’s scale and traffic resilience should outperform if consumer trade-down persists and input costs stay volatile.
• Watch KO as a lower-beta beneficiary of pricing power and distribution leverage; use it as a defensive long only if the market starts rewarding pass-through ability over unit growth, with a 6-12 month horizon.